Statements (16)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
|
gptkbp:activeIngredient |
gptkb:mitapivat
|
gptkbp:approvalYear |
2022
|
gptkbp:ATCCode |
V03AX05
|
gptkbp:form |
gptkb:tablet
|
https://www.w3.org/2000/01/rdf-schema#label |
PYRUKYND
|
gptkbp:indication |
pyruvate kinase deficiency
|
gptkbp:legalStatus |
prescription only
|
gptkbp:manufacturer |
gptkb:Agios_Pharmaceuticals
|
gptkbp:mechanismOfAction |
pyruvate kinase activator
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:status |
FDA approved
|
gptkbp:targetAudience |
adults
children |
gptkbp:bfsParent |
gptkb:Agios_Pharmaceuticals
|
gptkbp:bfsLayer |
5
|